Covestor Ltd
- SEC CIK
- 0001909846
- Latest filing
- Aug 7, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Covestor Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −76−100.0% | Sold out | Holders |
| Q4 2024 | 76 | $0 | 0.0% | +42+123.5% | Added | Holders |
| Q3 2024 | 34 | $0 | 0.0% | −2−5.6% | Reduced | Holders |
| Q2 2024 | 36 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 36 | $0 | 0.0% | −3−7.7% | Reduced | Holders |
| Q4 2023 | 39 | $0 | 0.0% | −3−7.1% | Reduced | Holders |
| Q3 2023 | 42 | $0 | 0.0% | −6−12.5% | Reduced | Holders |
| Q2 2023 | 48 | $0 | 0.0% | +21+77.8% | Added | Holders |
| Q1 2023 | 27 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2022 | 27 | $0 | 0.0% | −11−28.9% | Reduced | Holders |
| Q3 2022 | 38 | $0 | 0.0% | −7−15.6% | Reduced | Holders |
| Q2 2022 | 45 | $0 | 0.0% | +45 | New | Holders |